Description

4H-Quinolizine-3-Carboxylic Acid, 7-Bromo-4-Oxo-, Ethyl Ester is a specialized heterocyclic building block of significant interest in advanced organic synthesis. This compound matters as a key intermediate for constructing complex molecular architectures, particularly in pharmaceutical research and development. It is primarily needed by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for creating novel active ingredients and functional materials.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, infectious diseases, or oncology.
• Agrochemical Research: Used in the development of new herbicides, fungicides, or insecticides, leveraging its heterocyclic core for bioactivity.
• Material Science: Acts as a building block for organic electronic materials, such as organic light-emitting diodes (OLEDs) or semiconductors, due to its conjugated structure.
• Chemical Biology: Employed in the design and synthesis of molecular probes and tool compounds for studying biological pathways and enzyme functions.
• Academic Research: Utilized in universities and research institutes for methodological studies in heterocyclic and medicinal chemistry.
• Custom Synthesis: A starting material for contract research organizations (CROs) and CDMOs performing bespoke synthesis for client projects.

Basic Information

Product Name	4H-Quinolizine-3-Carboxylic Acid, 7-Bromo-4-Oxo-, Ethyl Ester
CAS No.	880869-90-9
Molecular Formula	C₁₃H₁₂BrNO₃
Molecular Weight	310.15 g/mol
Synonyms	Ethyl 7-Bromo-4-oxo-4H-quinolizine-3-carboxylate; 7-Bromo-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester; 4H-Quinolizine-3-carboxylic acid, 7-bromo-4-oxo-, ethyl ester; 7-Bromo-4-oxoquinolizine-3-carboxylic acid ethyl ester; Quinolizine derivative CAS 880869-90-9; Ethyl 7-bromo-4-oxo-1,4-dihydroquinolizine-3-carboxylate
EINECS	Contact for details

Quality Control

Our 4H-Quinolizine-3-Carboxylic Acid, 7-Bromo-4-Oxo-, Ethyl Ester is produced under strict quality management protocols. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.